Bengaluru-based HealthCare Global Enterprises (HCG) has deployed Sigtuple’s AI100 making HCG the first hospital chain to equip the Hematopathology labs across its network with AI-powered screening solutions for cancer detection and disease management.
SigTuple’s AI100 is the premier solution for AI-assisted digital hematopathology. It is also the only digital hematopathology solution available that is economical and robust enough for wide-scale adoption.
HCG's SigTuple's AI100 will help to automate the manual microscopy (screening) process across its network.
Dr. B.S. Ajaikumar, Executive Chairman, Healthcare Global Enterprises Limited (HCG) said, “AI-assisted digital scanning technology has indeed emerged as a game-changer in cancer care. Sigtuple’s best-in-class solution has brought remarkable precision to HCG’s Hematopathology diagnostic capabilities. The automation of key processes and optimization of logistics by virtue of this pioneering technology is a distinct value-add for HCG, given our overarching goal of serving the larger cause of patients through enhanced clinical outcomes”.
